https://www.selleckchem.com/pr....oducts/iacs-13909.ht
To achieve HCV elimination, DAA PA forms and processes should be standardized, streamlined, and ultimately removed.Objective To compare sustained virologic response 12 weeks post-treatment completion (SVR12) and patient characteristics for older versus younger patients with chronic hepatitis C virus infection (HCV) receiving direct-acting antiviral (DAA) agent therapy. Methods This retrospective cohort study included patients with chronic HCV who received DAA therapy, between 2015 and 2018, in the largest health system in Rhode Islan